Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)
Bausch Health Companies (BHC) reported Other Non Operating Income of -$11.0 million for Q1 2026, little changed sequentially from -$11.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Other Non Operating Income data on file, last reported at -$11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at -$59.0 million (down 255.26% YoY), and the FY2025 full-year result was -$52.0 million, down 326.09% from the prior year.
- Other Non Operating Income steadied at -$11.0 million in Q1 2026, from -$11.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $570.0 million in Q3 2022 to a low of -$30.0 million in Q2 2025.
- A 5-year average of $66.9 million and a median of -$7.0 million in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 9325.0% in 2022, while the deepest fall reached 800.0% in 2022.
- Tracing BHC's Other Non Operating Income over 5 years: stood at $369.0 million in 2022, then slumped by 99.73% to $1.0 million in 2023, then soared by 4800.0% to $49.0 million in 2024, then slumped by 122.45% to -$11.0 million in 2025, then changed by 0.0% to -$11.0 million in 2026.
- Business Quant data shows BHC's Other Non Operating Income at -$11.0 million in Q1 2026, -$11.0 million in Q4 2025, and -$7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -15.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | -7.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2022 | 369.00 Mn |
| Sep 30, 2022 | 570.00 Mn |
| Jun 30, 2022 | 113.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Sep 30, 2021 | -12.00 Mn |
| Jun 30, 2021 | 7.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 21.00 Mn |